DOCSLIB.ORG

Orchestration Between Ilc2s and Th2 Cells in Shaping Type 2 Immune Responses

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Orchestration Between Ilc2s and Th2 Cells in Shaping Type 2 Immune Responses Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses Rama Krishna Gurram1 and Jinfang Zhu1 The type 2 immune response is critical for host defense against large parasites such as helminths. On the other hand, dysregulation of the type 2 immune response may cause immunopathological conditions, including asthma, atopic dermatitis, rhinitis, and anaphylaxis. Thus, a balanced type 2 immune response must be achieved to mount effective protection against invading pathogens while avoiding immunopathology. The classical model of type 2 immunity mainly involves the differentiation of type 2 T helper (Th2) cells and the production of distinct type 2 cytokines, including interleukin-4 (IL-4), IL-5, and IL-13. Group 2 innate lymphoid cells (ILC2s) were recently recognized as another important source of type 2 cytokines. Although eosinophils, mast cells, and basophils can also express type 2 cytokines and participate in type 2 immune responses to various degrees, the production of type 2 cytokines by the lymphoid lineages, Th2 cells, and ILC2s in particular is the central event during the type 2 immune response. In this review, we discuss recent advances in our understanding of how ILC2s and Th2 cells orchestrate type 2 immune responses through direct and indirect interactions. Keywords: Type 2 immune response; type 2 T helper cell (Th2); Group 2 innate lymphoid cell (ILC2); Allergy and asthma Cellular & Molecular Immunology (2019) 16:225–235; https://doi.org/10.1038/s41423-019-0210-8 INTRODUCTION eosinophils from bone marrow into the tissue, leading to The type 2 immune response is mediated by various cytokines eosinophilic airway inflammation. IL-9 causes mast cell activation. that regulate diverse cellular functions, ranging from anti- IL-13 induces goblet cell hyperplasia, mucus hypersecretion and helminth parasite immunity to allergic inflammation, wound smooth muscle hyperreactivity. healing, and metabolism.1–6 A diverse variety of compounds, The traditional perception of type 2 immune responses is including macroscopic helminth worms, microscopic particles and largely focused on the generation of Th2 cells (Fig. 1). In this soluble enzymes, can elicit type 2 immune responses, which are model, antigen is taken up by specialized DCs, which then migrate orchestrated by several cell types.7 However, in this review, we will to local draining lymph nodes, where these DCs activate and mainly discuss the two major players in type 2 immune responses, instruct naïve CD4+ T cells to become Th2 cells. Differentiated Th2 namely, type 2 T helper (Th2) cells and group 2 innate lymphoid cells then egress from the lymph nodes and enter into the tissue, cells (ILC2s). where they produce effector cytokines IL-4, IL-5, and IL-13.11,12 The type 2 immune response often causes eosinophil recruit- However, this model cannot rationalize a rapid induction of the ment to inflamed sites, which is one of the characteristic features type 2 immune response in RAG-deficient mice, in which T cells of type 2 immunopathologies, including asthma, rhinitis, atopic are absent. dermatitis, and anaphylaxis.8,9 In addition to eosinophilia, such In recent years, it has become clear that, in addition to adaptive responses also include basophilia and the recruitment of mast lymphoid cells, there are lymphocyte-like innate cells that play cells and alternatively activated M2 macrophages. Asthma is the important roles in immunity and inflammation. These cells are one of the most prevalent type 2 immunopathologies. The clinical now designated as ILCs and are also considered the innate feature of asthma is airway obstruction, which directly results from counterparts of adaptive T helper cells. These cells can be the inflammation of airway mucosa-associated tissue. The type 2 classified into group 1 ILCs (ILC1s), which produce IFN-γ and immune response is elicited by the concatenated events enforced depend on the transcription factor T-bet for their development; by type 2 cytokines, including IL-4, IL-5, IL-9, and IL-13. IL-4 induces group 2 ILCs (ILC2s), which produce IL-5, IL-13, and IL-9 IgE production; then, IgE along with antigen forms immune and require GATA3; and group 3 ILCs (ILC3s), which mainly complexes that bind to high-affinity IgE receptors (FcεR1) on produce IL-22 and IL-17A and need RORγt for their development basophils and mast cells, causing the degranulation and release of and function.13–17 several proinflammatory mediators, such as histamine, heparin, In the context of type 2 immune responses, the discovery of and serotonin,10 which in turn are responsible for the immediate ILC2s has expanded our understanding from the classical DC-Th2- symptoms of the acute allergic response, including bronchocon- centric view to an ILC2-DC-Th2 axis (Fig. 2). In this new striction. IL-5 is responsible for the activation and recruitment of model, ILC2s are activated by epithelium-derived cytokines, 1Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA Correspondence: Rama Krishna Gurram ([email protected]) or Jinfang Zhu ([email protected]) Received: 30 November 2018 Accepted: 31 January 2019 Published online: 21 February 2019 © CSI and USTC 2019 Orchestration between ILC2s and Th2 cells in shaping type 2 immune. RK Gurram and J Zhu 226 bacteria, and helminths. The first step in the initiation of the type 2 immune response occurs when the products of allergens or helminths are sensed. Compared to bacterial and viral products, the immune initiation signals triggering a type 2 immune response are more complex, ranging from macroscopic helminths to microscopic particles, including chitins, pollens, house dust mites, and soluble enzymes (e.g., proteases). Upon exposure to helminth parasites or allergens, epithelial cells produce a variety of cytokines, including IL-1α, IL-33, IL-25, GM-CSF, and TSLP, and inflammatory mediators such as uric acid and ATP. Type 2 immunity requires the complex coordination of multiple cell types at the epithelial barrier. In response to type 2 stimuli, epithelial cells can also express chemokines, including CCL17, CCL22, and eotaxins (CCL11, CCL24, and CCL26), leading to the recruitment of DCs, eosinophils, basophils, mast cells, and Th2 cells.24 Epithelial cells also express a set of cytokines that educate DCs in promoting adaptive Th2 cell immunity and activate ILC2s, basophils, eosinophils, and mast cells.20,25–27 DCs exposed to IL-33 may promote the differentiation of IL-5- and IL-13-producing T helper cells from naïve CD4 T cells; the adoptive transfer of IL-33- treated DCs into naïve mice enhances lung airway inflammation.28 Fig. 1 Classic model of a type 2 immune response. In allergic Furthermore, TSLP induces OX40 ligand (OX40L) expression on asthma or during helminth infection, an allergen or a helminthic DCs, and OX40L expressed on activated DCs induces Th2 cell antigen is phagocytosed by dendritic cells, which then migrate to 29 + differentiation. the draining lymph node, where naïve CD4 T cells recognize the In addition to the alarmins, epithelial cells also produce danger- processed antigen presented by the peptide-MHC-II complex along associated molecular patterns (e.g., ATP and uric acid) upon with costimulatory molecules. After recognition of antigen pre- sented by dendritic cells (DCs), naïve CD4+ T cells differentiate into exposure to allergen. Both humans and mice were shown to 1234567890();,: effector Th2 cells. Th2 cells migrate into the site of inflammation and release ATP and uric acid in bronchoalveolar lavage upon 30,31 produce Th2 cytokines such as IL-5, which is responsible for exposure to HDM, which plays a crucial role in the induction eosinophilia, and IL-13, which promotes mucus production and of IL-25, IL-33, and TSLP secretion by epithelial cells. Furthermore, goblet cell hyperplasia. Th2 cells also produce IL-4, which is involved in response to ATP released from apoptotic epithelial cells after in antibody class switching and the production of IgE worm infection, mast cells may also produce IL-33 and thus are involved in the initiation of type 2 responses.32 Interestingly, IL-25 is constitutively expressed by tuft cells in the gut and is important including IL-33, IL-25, and thymic stromal lymphopoietin (TSLP).18 for maintaining ILC2 homeostasis.33–35 During a type 2 immune These molecules elicit the production of type 2 cytokines by ILC2s. response, IL-25 induces IL-13 production by ILC2s, and IL-13 Interestingly, ILC2s constitutively express certain levels of IL-5, produced by ILC2s and/or Th2 cells can promote the differentia- even in steady state, while IL-13 production is induced during type tion and expansion of tuft cells, resulting in a positive feedback 2inflammation.19 Although ILC2s mainly express IL-5 and IL-13, loop.33 The type 2 immune response also involves other cells, some ILC2s may express low levels of IL-4 under certain including alternatively activated M2 macrophages. The release of circumstances.20,21 In fact, IL-4 production by ILC2s may promote pro-inflammatory mediators by these cells is critical for expelling food allergy22 and induce Th2 cell differentiation during worm helminth parasites, although this process also causes significant infection.23 Type 2 cytokines secreted by either ILC2s or Th2 cells tissue damage and altered tissue function.4,36 (or both) result in
Load more

Recommended publications
  • Use of Mepolizumab in Adult Patients with Cystic Fibrosis and An
    Zhang et al. Allergy Asthma Clin Immunol (2020) 16:3 Allergy, Asthma & Clinical Immunology https://doi.org/10.1186/s13223-019-0397-3 CASE REPORT Open Access Use of mepolizumab in adult patients with cystic fbrosis and an eosinophilic phenotype: case series Lijia Zhang1, Larry Borish2,3, Anna Smith2, Lindsay Somerville2 and Dana Albon2* Abstract Background: Cystic fbrosis (CF) is characterized by infammation, progressive lung disease, and respiratory failure. Although the relationship is not well understood, patients with CF are thought to have a higher prevalence of asthma than the general population. CF Foundation (CFF) annual registry data in 2017 reported a prevalence of asthma in CF of 32%. It is difcult to diferentiate asthma from CF given similarities in symptoms and reversible obstructive lung function in both diseases. However, a specifc asthma phenotype (type 2 infammatory signature), is often identifed in CF patients and this would suggest potential responsiveness to biologics targeting this asthma phenotype. A type 2 infammatory condition is defned by the presence of an interleukin (IL)-4high, IL-5high, IL-13high state and is suggested by the presence of an elevated total IgE, specifc IgE sensitization, or an elevated absolute eosinophil count (AEC). In this manuscript we report the efects of using mepolizumab in patients with CF and type 2 infammation. Results: We present three patients with CF (63, 34 and 24 year of age) and personal history of asthma, who displayed signifcant eosinophilic infammation and high total serum IgE concentrations (type 2 infammation) who were treated with mepolizumab. All three patients were colonized with multiple organisms including Pseudomonas aeruginosa and Aspergillus fumigatus and tested positive for specifc IgE to multiple allergens.
    [Show full text]
  • Type 2 Immunity in Tissue Repair and Fibrosis
    REVIEWS Type 2 immunity in tissue repair and fibrosis Richard L. Gieseck III1, Mark S. Wilson2 and Thomas A. Wynn1 Abstract | Type 2 immunity is characterized by the production of IL‑4, IL‑5, IL‑9 and IL‑13, and this immune response is commonly observed in tissues during allergic inflammation or infection with helminth parasites. However, many of the key cell types associated with type 2 immune responses — including T helper 2 cells, eosinophils, mast cells, basophils, type 2 innate lymphoid cells and IL‑4- and IL‑13‑activated macrophages — also regulate tissue repair following injury. Indeed, these cell populations engage in crucial protective activity by reducing tissue inflammation and activating important tissue-regenerative mechanisms. Nevertheless, when type 2 cytokine-mediated repair processes become chronic, over-exuberant or dysregulated, they can also contribute to the development of pathological fibrosis in many different organ systems. In this Review, we discuss the mechanisms by which type 2 immunity contributes to tissue regeneration and fibrosis following injury. Type 2 immunity is characterized by increased pro‑ disorders remain unclear, although persistent activation duction of the cytokines IL‑4, IL‑5, IL‑9 and IL‑13 of tissue repair pathways is a major contributing mech‑ (REF. 1) . The T helper 1 (TH1) and TH2 paradigm was anism in most cases. In this Review, we provide a brief first described approximately three decades ago2, and overview of fibrotic diseases that have been linked to for many of the intervening years, type 2 immunity activation of type 2 immunity, discuss the various mech‑ was largely considered as a simple counter-­regulatory anisms that contribute to the initiation and maintenance mechanism controlling type 1 immunity3 (BOX 1).
    [Show full text]
  • T Cell Factor 1 Is Required for Group 2 Innate Lymphoid Cell Generation
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Immunity Article T Cell Factor 1 Is Required for Group 2 Innate Lymphoid Cell Generation Qi Yang,1 Laurel A. Monticelli,2 Steven A. Saenz,2 Anthony Wei-Shine Chi,1 Gregory F. Sonnenberg,2 Jiangbo Tang,3 Maria Elena De Obaldia,1 Will Bailis,1 Jerrod L. Bryson,1 Kristin Toscano,1 Jian Huang,4 Angela Haczku,4 Warren S. Pear,1 David Artis,2 and Avinash Bhandoola1,* 1Department of Pathology and Laboratory Medicine 2Department of Microbiology 3Department of Cancer Biology 4Department of Medicine Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.immuni.2012.12.003 SUMMARY 2012b; Hoyler et al., 2012; Moro et al., 2010; Wong et al., 2012). However, other transcription factors implicated in the Group 2 innate lymphoid cells (ILC2) are innate generation and function of ILC2 remain to be identified. lymphocytes that confer protective type 2 immunity ILC2 share many similarities with T cells. ILC2 derive from during helminth infection and are also involved in lymphoid progenitors and phenotypically resemble double- allergic airway inflammation. Here we report that negative 3 (DN3) cells that are committed to the T cell lineage ILC2 development required T cell factor 1 (TCF-1, (Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Wong the product of the Tcf7 gene), a transcription factor et al., 2012; Yang et al., 2011).
    [Show full text]
  • ILC2 Activation by Protozoan Commensal Microbes
    International Journal of Molecular Sciences Review ILC2 Activation by Protozoan Commensal Microbes Kyle Burrows 1 , Louis Ngai 1 , Flora Wong 1,2, David Won 1 and Arthur Mortha 1,* 1 University of Toronto, Department of Immunology, Toronto, ON M5S 1A8, Canada; [email protected] (K.B.) [email protected] (L.N.); fl[email protected] (F.W.); [email protected] (D.W.) 2 Ranomics, Inc. Toronto, ON M5G 1X5, Canada * Correspondence: [email protected] Received: 3 September 2019; Accepted: 27 September 2019; Published: 30 September 2019 Abstract: Group 2 innate lymphoid cells (ILC2s) are a member of the ILC family and are involved in protective and pathogenic type 2 responses. Recent research has highlighted their involvement in modulating tissue and immune homeostasis during health and disease and has uncovered critical signaling circuits. While interactions of ILC2s with the bacterial microbiome are rather sparse, other microbial members of our microbiome, including helminths and protozoans, reveal new and exciting mechanisms of tissue regulation by ILC2s. Here we summarize the current field on ILC2 activation by the tissue and immune environment and highlight particularly new intriguing pathways of ILC2 regulation by protozoan commensals in the intestinal tract. Keywords: ILC2; protozoa; Trichomonas; Tritrichomonas musculis; mucosal immunity; taste receptors; succinate; intestinal immunity; type 2 immunity; commensals 1. The ILC Lineage 1.1. The Family of Innate Lymphoid Cells Research over the last decade has redirected focus away from classical immune cell interactions within lymphoid tissues towards immunity within non-lymphoid tissues. Within these tissues, immune interactions involve local adaptation and rapid responses by tissue-resident immune cells.
    [Show full text]
  • Innate Lymphocytes—Lineage, Localization and Timing of Differentiation
    Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE Innate lymphocytes—lineage, localization and timing of differentiation Emily R. Kansler1,2 and Ming O. Li1 Innate lymphocytes are a diverse population of cells that carry out specialized functions in steady-state homeostasis and during immune challenge. While circulating cytotoxic natural killer (NK) cells have been studied for decades, tissue-resident innate lymphoid cells (ILCs) have only been characterized and studied over the past few years. As ILCs have been largely viewed in the context of helper T-cell biology, models of ILC lineage and function have been founded within this perspective. Notably, tissue- resident innate lymphocytes with cytotoxic potential have been described in an array of tissues, yet whether they are derived from the NK or ILC lineage is only beginning to be elucidated. In this review, we aim to shed light on the identities of innate lymphocytes through the lenses of cell lineage, localization, and timing of differentiation. Cellular & Molecular Immunology (2019) 16:627–633; https://doi.org/10.1038/s41423-019-0211-7 INTRODUCTION memory T cells have been described.3 Central memory T (Tcm) Lymphocytes are a fundamental component of the host immune cells are derived from CX3CR1− effector T cells and primarily response to challenge. Different classes of the lymphocyte circulate between the blood and secondary lymphoid organs. response are best defined by the type of effector programs Resident memory T (Trm) cells, although also derived from carried out by CD8+ or CD4+ T cells. CD8+ T cells are cytotoxic CX3CR1− effector T cells, enter peripheral tissues where they are lymphocytes that mediate a type 1 immune response to maintained locally by self-renewal and do not recirculate.
    [Show full text]
  • Atopic Dermatitis: an Expanding Therapeutic Pipeline for a Complex Disease
    REVIEWS Atopic dermatitis: an expanding therapeutic pipeline for a complex disease Thomas Bieber 1,2,3 Abstract | Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies. However, recent advances in understanding of disease mechanisms have led to the discovery of novel potential therapeutic targets and drug candidates. In addition to regulatory approval for the IL-4Ra inhibitor dupilumab, the anti- IL-13 inhibitor tralokinumab and the JAK1/2 inhibitor baricitinib in Europe, there are now more than 70 new compounds in development. This Review assesses the various strategies and novel agents currently being investigated for AD and highlights the potential for a precision medicine approach to enable prevention and more effective long-term control of this complex disease. Atopic disorders Atopic dermatitis (AD) is the most common chronic inhibitors tacrolimus and pimecrolimus and more 1,2 A group of disorders having in inflammatory skin disease . About 80% of disease cases recently the phosphodiesterase 4 (PDE4) inhibitor cris- common a genetic tendency to typically start in infancy or childhood, with the remain- aborole. For the more severe forms of AD, besides the develop IgE- mediated allergic der developing during adulthood. Whereas the point use of ultraviolet light, current therapeutic guidelines reactions. These are atopic dermatitis, food allergy, allergic prevalence in children varies from 2.7% to 20.1% across suggest ciclosporin A, methotrexate, azathioprine and 3,4 rhino- conjunctivitis and countries, it ranges from 2.1% to 4.9% in adults .
    [Show full text]
  • The Chemokine System in Innate Immunity
    Downloaded from http://cshperspectives.cshlp.org/ on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press The Chemokine System in Innate Immunity Caroline L. Sokol and Andrew D. Luster Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 Correspondence: [email protected] Chemokines are chemotactic cytokines that control the migration and positioning of immune cells in tissues and are critical for the function of the innate immune system. Chemokines control the release of innate immune cells from the bone marrow during homeostasis as well as in response to infection and inflammation. Theyalso recruit innate immune effectors out of the circulation and into the tissue where, in collaboration with other chemoattractants, they guide these cells to the very sites of tissue injury. Chemokine function is also critical for the positioning of innate immune sentinels in peripheral tissue and then, following innate immune activation, guiding these activated cells to the draining lymph node to initiate and imprint an adaptive immune response. In this review, we will highlight recent advances in understanding how chemokine function regulates the movement and positioning of innate immune cells at homeostasis and in response to acute inflammation, and then we will review how chemokine-mediated innate immune cell trafficking plays an essential role in linking the innate and adaptive immune responses. hemokines are chemotactic cytokines that with emphasis placed on its role in the innate Ccontrol cell migration and cell positioning immune system. throughout development, homeostasis, and in- flammation. The immune system, which is de- pendent on the coordinated migration of cells, CHEMOKINES AND CHEMOKINE RECEPTORS is particularly dependent on chemokines for its function.
    [Show full text]
  • NK Cell Development in Times of Innate Lymphoid Cell Diversity
    REVIEW published: 08 July 2020 doi: 10.3389/fimmu.2020.00813 NK Cell Development in Times of Innate Lymphoid Cell Diversity Vladislava Stokic-Trtica 1,2, Andreas Diefenbach 1,3,4* and Christoph S. N. Klose 1* 1 Department of Microbiology, Infectious Diseases and Immunology, Charité–Universitätsmedizin Berlin, Berlin, Germany, 2 Max-Planck Institute for Infection Biology, Berlin, Germany, 3 Berlin Institute of Health (BIH), Berlin, Germany, 4 Mucosal and Developmental Immunology, Deutsches Rheuma-Forschungszentrum, Berlin, Germany After being described in the 1970s as cytotoxic cells that do not require MHC-dependent pre-activation, natural killer (NK) cells remained the sole member of innate lymphocytes for decades until lymphoid tissue-inducer cells in the 1990s and helper-like innate lymphoid lineages from 2008 onward completed the picture of innate lymphoid cell (ILC) diversity. Since some of the ILC members, such as ILC1s and CCR6− ILC3s, share specific markers previously used to identify NK cells, these findings provoked the question of how to delineate the development of NK cell and helper-like ILCs and how to properly identify and genetically interfere with NK cells. The description of eomesodermin Edited by: (EOMES) as a lineage-specifying transcription factor of NK cells provided a candidate Ewa Sitnicka, Lund University, Sweden that may serve as a selective marker for the genetic targeting and identification of Reviewed by: NK cells. Unlike helper-like ILCs, NK cell activation is, to a large degree, regulated Gabrielle Belz, by the engagement of activating and inhibitory surface receptors. NK cell research Walter and Eliza Hall Institute of has revealed some elegant mechanisms of immunosurveillance, coined “missing-self” Medical Research, Australia Barbara L.
    [Show full text]
  • Innate Lymphoid Cells (Ilcs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis
    Downloaded from http://cshperspectives.cshlp.org/ on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis Maho Nagasawa, Hergen Spits, and Xavier Romero Ros Department of Experimental Immunology, Academic Medical Center at the University of Amsterdam, 1105 BA Amsterdam, Netherlands Correspondence: [email protected] Innate lymphoid cells (ILCs) have emerged as an expanding family of effector cells particu- larly enriched in the mucosal barriers. ILCs are promptly activated by stress signals and multiple epithelial- and myeloid-cell-derived cytokines. In response, ILCs rapidly secrete effector cytokines, which allow them to survey and maintain the mucosal integrity. Uncontrolled action of ILCs might contribute to tissue damage, chronic inflammation, met- abolic diseases, autoimmunity, and cancer. Here we discuss the recent advances in our understanding of the cytokine network that modulate ILC immune responses: stimulating cytokines, signature cytokines secreted by ILC subsets, autocrine cytokines, and cytokines that induce cell plasticity. nnate lymphoid cells (ILCs) are innate lym- Klose et al. 2014; Gasteiger et al. 2015). ILCs Iphocytes that play important roles in immune cross talk with the resident tissue by sensing defense against microbes, regulation of adaptive the cytokines present in their microenviron- immunity, tissue remodeling, and repair and ments and subsequently secreting a plethora homeostasis of hematopoietic and nonhemato- of cytokines that regulate innate immunity poietic cell types. ILCs are present in all tissues, and homeostasis of hematopoietic and nonhe- but they are particularly enriched in mucosal matopoietic cells in the tissues (Artis and Spits surfaces. Unlike adaptive lymphocytes, ILCs 2015).
    [Show full text]
  • Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
    International Journal of Molecular Sciences Review Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives Nicolas Jacquelot 1,* , Cyril Seillet 2,3 , Fernando Souza-Fonseca-Guimaraes 4, Adrian G. Sacher 1, Gabrielle T. Belz 2,3,4 and Pamela S. Ohashi 1,5 1 Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada; [email protected] (A.G.S.); [email protected] (P.S.O.) 2 Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC 3052, Australia; [email protected] (C.S.); [email protected] (G.T.B.) 3 Department of Medical Biology, University of Melbourne, Parkville, Melbourne, VIC 3010, Australia 4 Diamantina Institute, University of Queensland, 37 Kent Street, Woolloongabba, Brisbane, QLD 4102, Australia; [email protected] 5 Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada * Correspondence: [email protected] Abstract: Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) are specific innate lymphoid cell subsets that are key for the detection and elimination of pathogens and cancer cells. In liver, while they share a number of characteristics, they differ in many features. These include their developmental pathways, tissue distribution, phenotype and functions. NK cells and ILC1 contribute to organ homeostasis through the production of key cytokines and chemokines and the Citation: Jacquelot, N.; Seillet, C.; elimination of potential harmful bacteria and viruses. In addition, they are equipped with a wide Souza-Fonseca-Guimaraes, F.; Sacher, A.G.; Belz, G.T.; Ohashi, P.S.
    [Show full text]
  • Tumor Necrosis Factor Superfamily in Innate Immunity and Inflammation
    Downloaded from http://cshperspectives.cshlp.org/ on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Tumor Necrosis Factor Superfamily in Innate Immunity and Inflammation John Sˇ edy´, Vasileios Bekiaris, and Carl F. Ware Laboratory of Molecular Immunology, Infectious and Inflammatory Disease Center, Sanford Burnham Medical Research Institute, La Jolla, California 92037 Correspondence: [email protected] The tumor necrosis factor superfamily (TNFSF) and its corresponding receptor superfamily (TNFRSF) form communication pathways required for developmental, homeostatic, and stimulus-responsive processes in vivo. Although this receptor–ligand system operates between many different cell types and organ systems, many of these proteins play specific roles in immune system function. The TNFSF and TNFRSF proteins lymphotoxins, LIGHT (homologous to lymphotoxins, exhibits inducible expression, and competes with HSV gly- coprotein D for herpes virus entry mediator [HVEM], a receptor expressed by T lympho- cytes), lymphotoxin-b receptor (LT-bR), and HVEM are used by embryonic and adult innate lymphocytes to promote the development and homeostasis of lymphoid organs. Lymphotoxin-expressing innate-acting B cells construct microenvironments in lymphoid organs that restrict pathogen spread and initiate interferon defenses. Recent results illustrate how the communication networks formed among these cytokines and the coreceptors B and T lymphocyte attenuator (BTLA) and CD160 both inhibit and activate innate lymphoid cells (ILCs),
    [Show full text]
  • The Role of Dupilumab in Severe Asthma
    biomedicines Review The Role of Dupilumab in Severe Asthma Fabio Luigi Massimo Ricciardolo * , Francesca Bertolini and Vitina Carriero Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga University Hospital, Orbassano, 10043 Turin, Italy; [email protected] (F.B.); [email protected] (V.C.) * Correspondence: [email protected]; Tel.: +39-0119026777 Abstract: Dupilumab is a fully humanized monoclonal antibody, capable of inhibiting intracellular signaling of both interleukin (IL)-4 and IL-13. These are two molecules that, together with other proinflammatory cytokines such as IL-5 and eotaxins, play a pivotal role in orchestrating the airway inflammatory response defined as Type 2 (T2) inflammation, driven by Th2 or Type 2 innate lymphoid cells, which is the major feature of the T2 high asthma phenotype. The dual inhibition of IL-4 and IL-13 activities is due to the blockade of type II IL-4 receptor through the binding of dupilumab with the subunit IL-4Rα. This results in the repression of STAT6 and in the suppression of subsequent de novo formation of several molecules involved in the T2 inflammatory signature. Several clinical trials tested the efficacy and safety of dupilumab in large populations of uncontrolled severe asthmatics, revealing significant improvements in lung function, asthma control, and exacerbation rate. Similar results were reported when dupilumab was employed in patients harboring pathogenetic processes related to T2 immune response, such as atopic dermatitis and chronic rhinosinusitis. In this review, we provide an overview of the recent research in the field of respiratory medicine about dupilumab mechanism of action and its effects.
    [Show full text]